
|Articles|November 22, 2004
How ACCP is working on behalf of pharmacists
The inclusion of medication therapy management services (MTMS) as part of the new Medicare outpatient prescription drug benefit (Part D) was one of the American College of Clinical Pharmacy's priorities during the past year, said C. Edwin Webb, Pharm.D., M.P.H., ACCP's director for government and professional affairs. He told attendees at the ACCP annual meeting in Dallas last month that the Part D benefit, to be implemented in 2006, is focused on "high-risk" patients. Those considered to be high-risk require multiple medications, have multiple chronic conditions, and are likely to incur substantial medication costs, he explained.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Long-Term Adverse Effects After COVID-19 Vaccination Vary by Brand
2
Explaining COVID-19 Vaccine Side Effects to Anxious Patients
3
Expert Discusses Flu and COVID-19 Vaccine Guidance
4
Hormone Replacement Therapy May Lower Dementia Risk in Postmenopausal Women
5







































